STEPHANIE ROSAS: Open Payments
NPI 1285164012 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 102 payments from 20 companies in 2025. Trend: 2023 $1,706 · 2024 $2,055 · 2025 $2,363
Food & beverage: $2,363
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $331 |
| ABBVIE INC. | 18 | $295 |
| Enterra Medical, Inc. | 2 | $199 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $182 |
| GENZYME CORPORATION | 4 | $181 |
| QOL Medical, LLC | 6 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $165 |
| Celltrion USA Inc. | 5 | $114 |
| Madrigal Pharmaceuticals | 4 | $111 |
| Ipsen Biopharmaceuticals, Inc | 4 | $106 |
Products named: TREMFYA, LINZESS, DUPIXENT, Sucraid, XIFAXAN, VEGZELMA, REZDIFFRA, IQIRVO.
Industry payments across VA — which companies pay providers there.
